NFG
PDLI

Next Financial Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Next Financial Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,500
Closed -$17K – 2080
2015
Q3 		$17K Hold
3,500
– – 0.01% 1030
2015
Q2 		$22K Hold
3,500
– – 0.01% 977
2015
Q1 		$24K Sell
3,500
-12,050
-77% -$87.3K 0.01% 935
2014
Q4 		$120K Buy
15,550
+7,050
+83% +$55.8K 0.04% 406
2014
Q3 		$63K Buy
+8,500
New +$78.9K 0.01% 841

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Next Financial Group's PDLI Position: Q4 2015 in Review

Next Financial Group sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 3,500 shares — an estimated $17K sold.

Next Financial Group first reported a position in PDLI in Q3 2014 and held it in 5 quarters. The position peaked at $120K in Q4 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • Next Financial Group reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Next Financial Group sold 3,500 PDL BioPharma, Inc. shares in Q4 2015, an estimated $17K.
  • Next Financial Group first reported a position in PDL BioPharma, Inc. in Q3 2014 and held it in 5 quarters.
  • Next Financial Group's PDL BioPharma, Inc. position peaked at $120K in Q4 2014.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Next Financial Group's 13F filing for Q4 2015, filed 2 Feb 2016.